Publications by authors named "A de Havenon"
Background: Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic cardiovascular disease, including acute ischemic stroke (AIS), due to large- and small-vessel disease. Cholesterol management guidelines recommend lipid-lowering therapy (LLT) to prevent atherosclerotic cardiovascular disease events. This study assessed use of LLT at the time of AIS according to guideline recommendations and determined the association of prestroke LLT use with stroke severity.
View Article and Find Full Text PDFIntroduction: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular benefits in trials involving high-risk patients with type 2 diabetes (T2D), while dipeptidyl peptidase 4 inhibitors (DPP-4is) have not. However, DPP-4is are still commonly prescribed in patients with T2D and atherosclerotic cardiovascular disease (ASCVD). This study compared time to occurrence of cardiovascular events, health care resource utilization (HCRU), and medical costs in patients with T2D and ASCVD who initiated once-weekly semaglutide vs a DPP-4i.
View Article and Find Full Text PDFBackground And Objectives: The neurologic examination is a key part of neurologist visits. The neurologic examination leads to more accurate diagnoses, avoidance of unnecessary tests and procedures, and a stronger doctor-patient relationship. However, the neurologic examination takes time to perform, leading to longer visits with neurologists than with other specialists.
View Article and Find Full Text PDFArticle Synopsis
- This review discusses the advancements in low-field magnetic resonance imaging (LF-MRI) as a tool for diagnosing and monitoring cerebrovascular diseases such as strokes and white matter hyperintensities.
- Recent findings show that LF-MRI is beneficial due to its cost-effectiveness and versatility, making it suitable for various acute settings including emergency care and monitoring of chronic conditions.
- The review highlights the potential of LF-MRI technology to improve patient management by providing reliable neuroimaging options that are accessible across different healthcare environments.
Article Synopsis
- Portable low-field magnetic resonance imaging (LF-MRI) offers a promising way to assess Alzheimer's disease (AD) patients in places where traditional MRI isn't available, despite some limitations in image quality.
- * Researchers optimized LF-MRI techniques and created a free machine learning tool for analyzing brain structure and white matter changes in patients with cognitive impairments.
- * The study found that LF-MRI accurately measures hippocampal volumes and white matter hyperintensities, suggesting that this technology can improve access to neuroimaging for dementia patients at a lower cost.